Earnings Preview: DexCom to Report Financial Results Post-market on October 24
Where Will DexCom Be in 5 Years?
10 Health Care Stocks With Whale Alerts In Today's Session
The S&P 500 Election-year Implied Return From Now Until Year-end Reaches 6,200 – Analyst
DexCom (DXCM) Fell Due to Growth Deceleration
France Diabetes Devices Market Report (2024-2032) With Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom
Is DexCom, Inc. (NASDAQ:DXCM) The Top Stock With Improving Technical Ratings According To Piper Sandler?
Wolfe's Tax Loss Selling Stocks Within Communications, Discretionary, Staples, Energy, Financials, Health Care
Looking Into DexCom's Recent Short Interest
Down More Than 50% From Its High, Is DexCom Stock a Buy?
Blood Glucose Monitoring Devices Focused Market Insights 2024-2029 With Exclusive Data on 40 Vendors Including Key Players - F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia, and LifeScan IP
DexCom Is Maintained at Outperform by RBC Capital
DexCom Analyst Ratings
$100 Invested In This Stock 15 Years Ago Would Be Worth $3,600 Today
RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $120
DexCom Price Target Lowered to $120 From $130 at RBC Capital
Express News | Dexcom Inc : RBC Cuts Target Price to $120 From $130
CCORF Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $89
Are Investors Undervaluing DexCom, Inc. (NASDAQ:DXCM) By 45%?
Here's What to Expect From DexCom's Next Earnings Report